Épuisé, mais très demandé!
En savoir plus sur le livre
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.
Achat du livre
The Pharmagellan Guide to Biotech Forecasting and Valuation, Andrew Matthews, Frank S. David, Seth Robey
- Langue
- Année de publication
- 2017
- product-detail.submit-box.info.binding
- (souple)
Nous vous informerons par e-mail dès que nous l’aurons retrouvé.
Modes de paiement
Il manque plus que ton avis ici.
- Titre
- The Pharmagellan Guide to Biotech Forecasting and Valuation
- Langue
- Anglais
- Auteurs
- Andrew Matthews, Frank S. David, Seth Robey
- Éditeur
- Pharmagellan
- Publié
- 2017
- Format
- souple
- Pages
- 138
- ISBN10
- 099840750X
- ISBN13
- 9780998407500
- Séries
- Mots clés
- Nonfiction, Commerce, Affaires & Gestion, Économie, Finance
- Évaluation
- 4,3 sur 5
- Description
- If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.